In ESCC animal studies, the inhibition of CCL2-CCR2 axis could suppress tumor growth by blocking M2 macrophage recruitment and thus enhance the antitumor effect of CD8+ T cells [29]. The gene discussed is CD8A; the disease is esophageal squamous cell carcinoma.